XML 40 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Impairment, Restructuring and COVID-19 Related Charges
12 Months Ended
Jan. 28, 2023
Restructuring and Related Activities [Abstract]  
Impairment, Restructuring and COVID-19 Related Charges

17. Impairment, Restructuring and COVID-19 Related Charges

The following table represents impairment, restructuring and COVID-19 – related charges. All amounts were recorded within impairment, restructuring and COVID-19 – related charges on the Consolidated Statements of Operations, unless otherwise noted.

 

 

 

For the years ended

 

 

 

January 28,

 

 

January 29,

 

 

January 30,

 

(In thousands)

 

2023

 

 

2022

 

 

2021

 

Long-lived asset impairment charges (1) (2) (3)

 

$

20,633

 

 

$

11,944

 

 

$

249,163

 

Incremental COVID-19 – related expenses (4)

 

 

 

 

 

 

 

 

26,930

 

Severance and related employee costs

 

 

1,576

 

 

 

 

 

 

3,733

 

Total impairment, restructuring, and COVID-19 – related charges

 

$

22,209

 

 

$

11,944

 

 

$

279,826

 

 

(1)
The Company recorded impairment charges of $20.6 million in Fiscal 2022, of which $13.1 million relates to operating lease store ROU assets and $4.0 million relates to store property and equipment (store fixtures and leasehold improvements), and $3.5 million of other assets.
(2)
The Company recorded impairment charges of $11.9 million in Fiscal 2021, of which $4.1 million relates to operating lease store ROU assets and $5.2 million relates to store property and equipment (store fixtures and leasehold improvements), and $2.6 million of other assets.
(3)
In Fiscal 2020, the Company recorded impairment charges of $249.2 million. Included in this amount are retail store impairment charges of $203.2 million, of which $154.8 million relates to operating lease ROU assets and $48.4 million relates to store property and equipment (fixtures and equipment and leasehold improvements). We also recorded $28.0 million related to the impairment of certain corporate property and equipment, as well as $18.0 million of certain cost and equity method investments.
(4)
Incremental COVID-19 related expenses consisting of personal protective equipment and supplies for our associates and customers.